183 related articles for article (PubMed ID: 33402483)
1. Metabolic-targeted Combination Therapy With Dichloroacetate and Metformin Suppresses Glioblastoma Cell Line Growth
Korsakova L; Krasko JA; Stankevicius E
In Vivo; 2021; 35(1):341-348. PubMed ID: 33402483
[TBL] [Abstract][Full Text] [Related]
2. Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells.
Haugrud AB; Zhuang Y; Coppock JD; Miskimins WK
Breast Cancer Res Treat; 2014 Oct; 147(3):539-50. PubMed ID: 25212175
[TBL] [Abstract][Full Text] [Related]
3. Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1.
Kim TS; Lee M; Park M; Kim SY; Shim MS; Lee CY; Choi DH; Cho Y
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576192
[TBL] [Abstract][Full Text] [Related]
4. Metformin enhances cytotoxic action of dichloroacetate against Lewis lung carcinoma cells in vitro.
Kolesnik DL; Pyaskovskaya ON; Gorbach O; Solyanik GI
Exp Oncol; 2020 Mar; 42(1):35-39. PubMed ID: 32231186
[TBL] [Abstract][Full Text] [Related]
5. Complex I inhibition augments dichloroacetate cytotoxicity through enhancing oxidative stress in VM-M3 glioblastoma cells.
Ward NP; Poff AM; Koutnik AP; D'Agostino DP
PLoS One; 2017; 12(6):e0180061. PubMed ID: 28644886
[TBL] [Abstract][Full Text] [Related]
6. Targeting Cancer Cell Metabolism with Metformin, Dichloroacetate and Memantine in Glioblastoma (GBM).
Albayrak G; Konac E; Dere UA; Emmez H
Turk Neurosurg; 2021; 31(2):233-237. PubMed ID: 33372258
[TBL] [Abstract][Full Text] [Related]
7. Metformin enhances antitumor action of sodium dichloroacetate against glioma C6.
Kolesnik DL; Pyaskovskaya ON; Yurchenko OV; Solyanik GI
Exp Oncol; 2019 Jun; 41(2):123-129. PubMed ID: 31262158
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent cytotoxicity of dichloroacetate and metformin against Lewis lung carcinoma.
Kolesnik DL; Pyaskovskaya ON; Yakshibaeva YR; Solyanik GI
Exp Oncol; 2019 Mar; 41(1):14-19. PubMed ID: 30932416
[TBL] [Abstract][Full Text] [Related]
9. Dichloroacetate and metformin synergistically suppress the growth of ovarian cancer cells.
Li B; Li X; Ni Z; Zhang Y; Zeng Y; Yan X; Huang Y; He J; Lyu X; Wu Y; Wang Y; Zheng Y; He F
Oncotarget; 2016 Sep; 7(37):59458-59470. PubMed ID: 27449090
[TBL] [Abstract][Full Text] [Related]
10. Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells.
Florio R; De Lellis L; Veschi S; Verginelli F; di Giacomo V; Gallorini M; Perconti S; Sanna M; Mariani-Costantini R; Natale A; Arduini A; Amoroso R; Cataldi A; Cama A
Sci Rep; 2018 Sep; 8(1):13610. PubMed ID: 30206358
[TBL] [Abstract][Full Text] [Related]
11. Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1.
Voltan R; Rimondi E; Melloni E; Gilli P; Bertolasi V; Casciano F; Rigolin GM; Zauli G; Secchiero P
Oncotarget; 2016 Apr; 7(14):18965-77. PubMed ID: 26959881
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells.
Choi YW; Lim IK
Cancer Lett; 2014 May; 346(2):300-8. PubMed ID: 24480191
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia enhances antitumor activity of dichloroacetate.
Kolesnik DL; Pyaskovskaya ON; Boichuk IV; Solyanik GI
Exp Oncol; 2014 Dec; 36(4):231-5. PubMed ID: 25537215
[TBL] [Abstract][Full Text] [Related]
14. Dual-targeting of aberrant glucose metabolism in glioblastoma.
Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL
J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202
[TBL] [Abstract][Full Text] [Related]
15. Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model.
Su L; Zhang H; Yan C; Chen A; Meng G; Wei J; Yu D; Ding Y
Oncotarget; 2016 Oct; 7(40):65721-65731. PubMed ID: 27582548
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
17. Dichloroacetate induced intracellular acidification in glioblastoma: in vivo detection using AACID-CEST MRI at 9.4 Tesla.
Albatany M; Li A; Meakin S; Bartha R
J Neurooncol; 2018 Jan; 136(2):255-262. PubMed ID: 29143921
[TBL] [Abstract][Full Text] [Related]
18. Dichloroacetate and PX-478 exhibit strong synergistic effects in a various number of cancer cell lines.
Parczyk J; Ruhnau J; Pelz C; Schilling M; Wu H; Piaskowski NN; Eickholt B; Kühn H; Danker K; Klein A
BMC Cancer; 2021 Apr; 21(1):481. PubMed ID: 33931028
[TBL] [Abstract][Full Text] [Related]
19. Dichloroacetate induces tumor-specific radiosensitivity in vitro but attenuates radiation-induced tumor growth delay in vivo.
Zwicker F; Kirsner A; Peschke P; Roeder F; Debus J; Huber PE; Weber KJ
Strahlenther Onkol; 2013 Aug; 189(8):684-92. PubMed ID: 23793865
[TBL] [Abstract][Full Text] [Related]
20. Targeting of two aspects of metabolism in breast cancer treatment.
Gang BP; Dilda PJ; Hogg PJ; Blackburn AC
Cancer Biol Ther; 2014; 15(11):1533-41. PubMed ID: 25482950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
